NEW YORK – Uppsala University spinout Readily Diagnostics is using technology built off 30 years of research as the basis of a point-of-care, instrument-free test that would detect and differentiate ...

According to SNS Insider Report, The Rising Demand for Biologics and Cell Therapy Drives Accelerated Growth in the Mycoplasma Testing Market.Austin, May 01, 2025 (GLOBE NEWSWIRE) -- Mycoplasma Testing ...

The company said that its test could overcome sensitivity issues with ultrasound and serum alpha-fetoprotein assays that are used to monitor at-risk patients.

Introduction: The ELISA Analyzers Market is poised for significant growth, driven by a surge in demand for advanced diagnostic tools in healthcare. Valued at approximately USD 567.88 million in 2022, ...